166 related articles for article (PubMed ID: 9215424)
1. Managing patients with primary pulmonary hypertension: prostacyclin therapy.
Albert NM; Hague K
Am J Crit Care; 1997 Jul; 6(4):274-80. PubMed ID: 9215424
[No Abstract] [Full Text] [Related]
2. Epoprostenol (prostacyclin) therapy in primary pulmonary hypertension.
Botney M
N Engl J Med; 1998 Jun; 338(24):1773-4. PubMed ID: 9625639
[No Abstract] [Full Text] [Related]
3. Epoprostenol therapy for primary pulmonary hypertension.
Cheever KH; Kitzes B; Genthner D
Crit Care Nurse; 1999 Aug; 19(4):20-7. PubMed ID: 10614244
[TBL] [Abstract][Full Text] [Related]
4. Intravenous epoprostenol: a new therapy for primary pulmonary hypertension.
Sabo JA; Nord CP
Crit Care Nurse; 2000 Dec; 20(6):31-40. PubMed ID: 11878257
[No Abstract] [Full Text] [Related]
5. Timeline of haemodynamic improvement with subcutaneous prostacyclin therapy in a patient with severe pulmonary arterial hypertension.
Sadushi-Koliçi R; Perthold W; Fruhwald FM; Lang IM
Eur J Clin Invest; 2008 Aug; 38(8):603-4. PubMed ID: 18573098
[No Abstract] [Full Text] [Related]
6. Advances in prostacyclin therapy for pulmonary arterial hypertension.
Eells PL
Crit Care Nurse; 2004 Apr; 24(2):42-8, 50-4. PubMed ID: 15098310
[No Abstract] [Full Text] [Related]
7. [Therapy of severe pulmonary hypertension with prostacyclin and iloprost].
Matthes J; Mathen F; Herzig S; Wassermann K
Dtsch Med Wochenschr; 2001 May; 126(21):631-7. PubMed ID: 11413752
[No Abstract] [Full Text] [Related]
8. Prostacyclin therapy for pulmonary arterial hypertension: new directions.
Gomberg-Maitland M; Preston IR
Semin Respir Crit Care Med; 2005 Aug; 26(4):394-401. PubMed ID: 16121316
[TBL] [Abstract][Full Text] [Related]
9. Practical aspects of continuous intravenous treprostinil therapy.
Widlitz AC; McDevitt S; Ward GR; Krichman A
Crit Care Nurse; 2007 Apr; 27(2):41-2, 44-5, 47-50; quiz 51. PubMed ID: 17389412
[No Abstract] [Full Text] [Related]
10. Pharmacokinetic evaluation of continuous intravenous epoprostenol.
Chaumais MC; Jobard M; Huertas A; Vignand-Courtin C; Humbert M; Sitbon O; Rieutord A; Montani D
Expert Opin Drug Metab Toxicol; 2010 Dec; 6(12):1587-98. PubMed ID: 21077785
[TBL] [Abstract][Full Text] [Related]
11. Cutaneous findings in patients with pulmonary arterial hypertension receiving long-term epoprostenol therapy.
Myers SA; Ahearn GS; Angelica Selim M; Tapson VF
J Am Acad Dermatol; 2004 Jul; 51(1):98-102. PubMed ID: 15243533
[TBL] [Abstract][Full Text] [Related]
12. Recurrent portopulmonary hypertension after liver transplantation: management with epoprostenol and resolution after retransplantation.
Kett DH; Acosta RC; Campos MA; Rodriguez MJ; Quartin AA; Schein RM
Liver Transpl; 2001 Jul; 7(7):645-8. PubMed ID: 11460234
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary hypertension update.
Hesselgrave B
Case Manager; 2005; 16(6):61-6; quiz 67. PubMed ID: 16326325
[No Abstract] [Full Text] [Related]
14. Twin pregnancy in a woman on long-term epoprostenol therapy for primary pulmonary hypertension. A case report.
Badalian SS; Silverman RK; Aubry RH; Longo J
J Reprod Med; 2000 Feb; 45(2):149-52. PubMed ID: 10710749
[TBL] [Abstract][Full Text] [Related]
15. Successful transition from intravenous to inhaled prostacyclin in a patient with pulmonary hypertension and right ventricular failure.
Reddy MT; Patel H; Ventura HO
Congest Heart Fail; 2008; 14(5):285-6. PubMed ID: 18983294
[No Abstract] [Full Text] [Related]
16. Pulmonary edema during acute infusion of epoprostenol in a patient with pulmonary hypertension and limited scleroderma.
Farber HW; Graven KK; Kokolski G; Korn JH
J Rheumatol; 1999 May; 26(5):1195-6. PubMed ID: 10332990
[TBL] [Abstract][Full Text] [Related]
17. Prostacycline (Flolan). Intravenous nursing responsibilities in the care of the patient with primary pulmonary hypertension.
Benvenuto DB
J Intraven Nurs; 1999; 22(5):267-72. PubMed ID: 10776190
[TBL] [Abstract][Full Text] [Related]
18. Long-term follow-up of portopulmonary hypertension: effect of treatment with epoprostenol.
Fix OK; Bass NM; De Marco T; Merriman RB
Liver Transpl; 2007 Jun; 13(6):875-85. PubMed ID: 17539008
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary hypertension--beyond vasodilator therapy.
Fishman AP
N Engl J Med; 1998 Jan; 338(5):321-2. PubMed ID: 9445414
[No Abstract] [Full Text] [Related]
20. High levels of nitric oxide in individuals with pulmonary hypertension receiving epoprostenol therapy.
Ozkan M; Dweik RA; Laskowski D; Arroliga AC; Erzurum SC
Lung; 2001; 179(4):233-43. PubMed ID: 11891614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
